HDAC6: A Key Link Between Mitochondria and Development of Peripheral Neuropathy.

Area of Science:

• Neuroscience
• Mitochondrial Biology
• Pharmacology

Background:

• Peripheral neuropathy and neuropathic pain are significant health concerns.
• Traditional research focuses on ion channels and receptors, but mitochondrial dysfunction is increasingly recognized.
• The role of Class IIb histone deacetylase (HDAC6) in neuropathy is under investigation.

Purpose of the Study:

• To review the connection between peripheral neuropathy, mitochondrial dysfunction, and HDAC6.
• To explore HDAC6 as a potential therapeutic target for neuropathic pain.

Main Methods:

• Review of current literature on HDAC6, mitochondrial dynamics, and peripheral neuropathy.
• Analysis of in vivo and in vitro studies investigating HDAC6 inhibition.

Main Results:

• Mitochondrial dysfunction, including altered transport, metabolism, and dynamics, contributes to neuropathy.
• HDAC6 regulates mitochondrial dynamics and may drive dysfunction in peripheral neuropathy.
• HDAC6 inhibition shows significant potential in alleviating neuropathy and pain in preclinical models.

Conclusions:

• HDAC6 plays a critical role in mediating mitochondrial dysfunction in peripheral neuropathy.
• HDAC6 inhibitors represent a promising therapeutic strategy for peripheral neuropathic disorders.